Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the domain of hematological malignancies. Novel treatment modalities such as targeted drugs, immunotherapies, and therapy are altering the prognosis for patients with blood cancers. Ongoing investigations continue to explore these innovative strategies, offering promise for more successful treatment